GIS

Gilead Sciences, Inc. · XETR:GIS

152.10 EUR1.42 +0.94%

Gilead Sciences, Inc. (XETR:GIS) last traded at 152.10 EUR, up 0.94% on the day. Over the past year the stock is up 46.14%. Its 52-week range is 99.98 to 156.38. It is in the Health Technology sector (Biotechnology).

Key statistics

Open152.42

Day range151.78 – 153.80

52-week range99.98 – 156.38

Volume798

Average volume (10 days)1.36 K

Market cap (USD)211.27 B

EPS (TTM) (USD)−3.15

Dividend yield1.91%

Beta (1 year)0.1933

Revenue (TTM) (USD)31.06 B

Employees17.00 K

Performance

+7.32%1 week

+15.89%1 month

+31.46%3 months

+30.67%6 months

+44.97%Year to date

+46.14%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Dr. Reddy's granted FDA nod for first generic targeting Gilead’s YeztugoSeeking Alpha · 03 Nov 2026
How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.